ResMed (RMD)
(Delayed Data from NYSE)
$216.98 USD
-1.17 (-0.54%)
Updated May 3, 2024 04:00 PM ET
After-Market: $217.10 +0.12 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (151 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.68 | 1.69 | 9.99 |
Current Quarter Estimate | 1.99 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 1.60 | 4.88 | 52.54 |
Next Quarter Estimate | 2.02 | 7.06 | 61.00 |
Next Year Estimate | 8.58 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 17.86 | 18.40 | 15.67 |
Next Year | 13.04 | 24.30 | 9.31 |
Last 5 Years | 14.00 | 4.00 | 8.10 |
Next 5 Years | 10.70 | 10.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 29.93 | -13.85 |
Price/Book (MRQ) | 6.88 | 1.90 |
Price/Cash Flow (MRFY) | 27.79 | 10.67 |
Dividend Yield | 0.88% | 0.00% |
Net Profit Margin (TTM) | 20.91% | 12.53% |
Return on Equity (TTM) | 24.43% | 13.71% |
Debt to Equity (MRQ) | 0.22 | 19.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.